At a glance
ClinicalIndex Comparison Record- ✓Age 18–65 years
- ✓Confirmed diagnosis of bipolar disorder
- ✓Currently experiencing symptoms of impulsivity
- ✓Vision normal or corrected to normal with contacts
- ✕Currently in depressive, manic, or mixed episode
- ✕Currently psychotic
- ✕Assessed as at serious and imminent suicidal risk
- ✕Active alcohol or substance use disorder (meeting criteria in past 3 months)
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Transcranial Photobiomodulation for Executive Function in Bipolar Disorder (TPEB)
In Brief
A Phase 2 clinical trial evaluating Transcranial Phoobiomodulation (tPBM) for Bipolar Disorder. Completed, enrolled 13 participants across 1 site.
Detailed Summary
Transcranial light therapy, or transcranial photobiomodulation (tPBM), is a treatment that stimulates the brain by applying near-infrared light to the forehead. Transcranial light therapy has been found to promote brain metabolism, which may help improve executive function in people with bipolar disorder. The research team proposes a novel approach to treating bipolar disorder by using transcranial light therapy.
Study Details
Timeline
Interventions
Transcranial light therapy penetrates the skin and brain using light energy; this makes transcranial light therapy noninvasive. Transcranial light therapy may activate under-stimulated brain regions.